AI Could Speed Up Cancer Treatment Discoveries, but Chip Shortages Are Slowing Progress

Artificial intelligence could play a major role in developing new cancer treatments, but a shortage of advanced computer chips is slowing the expansion of the technology, according to the boss of one of the UK's biggest technology companies.                                                                                                              

                                 

Rene Haas, chief executive of Cambridge-based chip designer Arm Holdings, said he believes AI could eventually help scientists solve some of the most complex problems associated with cancer. He argued that increasingly powerful computers could allow researchers to analyse biological and genetic data at a scale that is difficult to achieve today.

Haas said modelling how changes in DNA markers are affected by cancer remains an extremely complex task. However, he believes advances in computing and artificial intelligence could eventually make such problems much easier to understand.

His comments highlight the growing expectations surrounding AI in healthcare. Researchers are already using artificial intelligence to analyse medical images, study biological data and assist in the search for potential drugs. However, turning promising AI research into proven treatments still requires extensive laboratory work, clinical trials and regulatory approval.

At the same time, Haas warned that the rapid growth of AI is facing a major infrastructure challenge. The demand for powerful chips needed to operate AI systems and build large data centres has created supply constraints across the technology industry.

According to Haas, the shortage could limit how quickly companies expand the computing capacity required for increasingly sophisticated AI systems. He pointed to plans for huge data centres in countries including the United States and France as examples of the scale of investment now being considered.

The chip shortage is part of a broader surge in demand driven by the global AI boom. Advanced processors and high-performance memory are increasingly needed to train and operate sophisticated AI models, putting pressure on semiconductor supply chains.

Haas also expressed doubts about whether the UK needs to build large numbers of chip manufacturing plants domestically, arguing that semiconductor fabrication requires significant investment, specialised workers and other resources.

Arm itself plays an important role in the global technology industry. Its chip designs are used in smartphones, vehicles, smartwatches and numerous other electronic devices around the world.

While Haas's prediction about AI and cancer is ambitious, experts generally caution that AI should be viewed as a tool that can accelerate scientific research rather than a guaranteed route to a cure. Any potential treatment identified with the help of AI would still need to undergo rigorous testing before it could be approved for patients.

The combination of rapidly advancing AI and limited chip supplies therefore presents both an opportunity and a challenge. As computing technology becomes more powerful, researchers could gain new tools for tackling difficult diseases, but the infrastructure needed to support that progress must expand at the same time.